Weill Cornell lab helps translate ideas into innovations

The Dean's Entrepreneurship Lab provides resources and education opportunities to students and faculty who have ideas with commercial potential that they want to translate from the lab to the patient.

New technique improves blood flow to damaged tissues

A gene essential for making blood vessels in embryos can successfully transform amniotic cells into therapeutic blood vessel cells, according to new research from Weill Cornell Medicine.

Brain cells mobilize sugar in response to increased activity

New research from Weill Cornell Medicine provides insights into why the brain is so reliant on sugar to function.

New host-microbe institute connects campus researchers

The university launched the Cornell Institute of Host-Microbe Interactions and Disease, an organization that connects the community of Cornell researchers studying host-microbe biology and disease.

Dr. Augustine M.K. Choi named dean of Weill Cornell Medicine

Choi unanimously was elected the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Cornell's provost for medical affairs Jan. 17.

'Radical collaboration' sets its sights on cancer treatment

Lewis C. Cantley and Kristy Richards are growing radically collaborative research connections between Weill Cornell Medicine and the College of Veterinary Medicine.

Tailored organoid may help unravel immune response mystery

Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.

Softening of tumor tissue could aid in cancer drug delivery

A Cornell research group reports that a mechanical factor - stiffening of a cancer cell and its matrix - and not a chemical cause could contribute to metastasis in some forms of cancer.

As routine screenings drop, prostate cancer on rise in older men

The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.